rocky start for alzheimers research
Last Updated : GMT 09:03:51
Almaghrib Today, almaghrib today
Almaghrib Today, almaghrib today
Last Updated : GMT 09:03:51
Almaghrib Today, almaghrib today

In 2018

Rocky start for Alzheimer's research

Almaghrib Today, almaghrib today

Almaghrib Today, almaghrib today Rocky start for Alzheimer's research

Designer Guio Di Colombia in Inclusion fashion show in Colombia.
Paris - Al Maghrib Today

The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Within the first three weeks, pharmaceutical giant Pfizer abandoned the costly and frustrating field of dementia drug development, and two promising treatments stumbled in patient trials.

Alzheimer's support groups are putting on a brave face, but the collective disappointment is palpable as the global cost of caring for some 50 million dementia sufferers is set to reach $1 trillion (819 billion euros) this year.

"It's very fair to say that progress is slow," David Reynolds, chief scientific officer at Alzheimer's Research UK, a charity, told AFP.

"Companies have put a lot of time, effort and money in over the last 25 years, and there haven't been any new medicines launched in this area for 16 years now."

Experts say it takes 12–15 years, on average, and more than $2 billion to develop a single drug.

According to the Alzforum website, which gathers data on candidate drugs, fewer than 300 have made it to Phase II drug efficiency trials so far.

Only five have ever been approved to treat symptoms such as memory loss associated with Alzheimer's, first identified more than 100 years ago.

With a clinical trial failure rate of over 99 percent, there is still no licenced drug that slows the condition's progression, or cures it.

Today, about 100 candidate dementia drugs are enrolled in trials, compared to over 1,000 for cancer, according to Reynolds.

One reason is that "pharmaceutical companies ultimately are companies. They are beholden to their investors," he said.

"A return on investment is really: How much time and money do you put into getting a new medicine versus how much money can you make once you've actually got it? In this area, success has been very difficult to come by."

- Mysterious brain -

The stakes are high.

According to the World Health Organization (WHO), some 10 million people per year are diagnosed with dementia, with Alzheimer's disease accounting for about two-thirds of cases.

By 2030, the number of sufferers is projected to reach 82 million globally, and by 2050 some 152 million.

The medical, patient-care, and economic costs are enormous.

A heavy burden falls on family members, the majority of care providers worldwide. Many have to give up their jobs.

Alzheimer's affects mainly older people -- about one in four over-85s is a sufferer. And numbers have soared as lifespans have lengthened thanks to medical advances in other fields.

With cardiovascular disease and cancer the biggest killers in the 1960s and '70s, that is where most of the research money went.

"In dementia, that investment wasn't there. So the amount of knowledge... about the disease is at a much, much earlier stage, and arguably the brain is a much more complicated organ" than the heart, said Reynolds.

To this day, scientists don't know exactly what causes Alzheimer's, leaving drug developers stumped.

On January 6, Pfizer announced an end to its "discovery and early development efforts" for Alzheimer's and Parkinson's dementia drugs.

Two days later, Danish company Lundbeck reported its idalopirdine compound did not "decrease cognitive loss" in patients, and on January 12, biotech firm Axovant announced the end of the road for its offering, intepirdine.

- Slow, but not backwards -

Experts say every failure of a drug reveals something new about Alzheimer's disease, which is thought to be associated with a buildup of protein "plaques", and "tangles" in the brain.

One important recent realisation was that an effective treatment may have to begin long before symptoms appear as protein build-up likely starts decades before disease sets in.

This, in itself, presents a research challenge.

"How do you find these patients?" when they are in middle age and symptom-free, explained French neurology professor Bruno Dubois. "How long do you treat them?"

Drugs in development today are targeting several tracks.

Some use antibodies to mop up proteins in circulation, or enzymes to inhibit their production.

Another experimental approach is vaccination: training the body to produce its own antibodies to attack disease-causing proteins.

"We are not moving backwards," insisted Reynolds.

Yet, he was "by no means certain" that a goal set by the G8 in 2013 to develop a cure or treatment for dementia by 2025 can be met.

"Even knowing the obstacles, we have never been as optimistic as we are today," added James Hendrix, a director at the US-based Alzheimer's Association, one of several non-profit research funders.

"We will not slow down in our fight against this terrible disease," he vowed.

"We are steadfastly committed to both advocating for further increased federal funding for Alzheimer's and dementia research, and increasing our own level of research funding to get us to where we ultimately need to be -- a world without Alzheimer's disease."

Source: AFP

almaghribtoday
almaghribtoday

GMT 12:12 2018 Wednesday ,17 January

Pretty dresses are no longer just

GMT 12:50 2018 Tuesday ,16 January

Lacobella appoints 5th House PR

GMT 10:16 2018 Monday ,15 January

Dolce & Gabbana's royal flush wows

GMT 15:17 2018 Sunday ,14 January

The Dovetail Agency launches events

GMT 09:25 2018 Friday ,12 January

Uniqlo fashions strong profits

GMT 11:54 2018 Thursday ,11 January

Versace family slam TV series

GMT 07:15 2018 Wednesday ,10 January

Fashion East confirmed for Fashion

GMT 08:20 2018 Tuesday ,09 January

Dior Paris fashion exhibition breaks
Almaghrib Today, almaghrib today

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

rocky start for alzheimers research rocky start for alzheimers research

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

rocky start for alzheimers research rocky start for alzheimers research

 



Almaghrib Today, almaghrib today Skincare PR Performance Full Year 2017

GMT 09:22 2018 Monday ,22 January

Skincare PR Performance Full Year 2017
Almaghrib Today, almaghrib today New hunt for flight MH370 gets under way

GMT 11:03 2018 Wednesday ,24 January

New hunt for flight MH370 gets under way
Almaghrib Today, almaghrib today Modern colorful bedroom renovation

GMT 10:57 2017 Thursday ,21 December

Modern colorful bedroom renovation
Almaghrib Today, almaghrib today Puigdemont candidate for Catalan president

GMT 13:56 2018 Tuesday ,23 January

Puigdemont candidate for Catalan president
Almaghrib Today, almaghrib today Turkey detains dozens more

GMT 10:47 2018 Wednesday ,24 January

Turkey detains dozens more
Almaghrib Today, almaghrib today The Rake announces editorial updates

GMT 10:46 2018 Tuesday ,16 January

The Rake announces editorial updates
Almaghrib Today, almaghrib today Europe brings on charm and blue skies

GMT 11:51 2018 Tuesday ,23 January

Europe brings on charm and blue skies
Almaghrib Today, almaghrib today For the Variety of Interior Design Styles

GMT 10:46 2017 Tuesday ,19 December

For the Variety of Interior Design Styles
Almaghrib Today, almaghrib today US Christian tourists see deep meaning

GMT 13:44 2018 Monday ,22 January

US Christian tourists see deep meaning
Almaghrib Today, almaghrib today Amazon to open first cashierless shop

GMT 10:03 2018 Tuesday ,23 January

Amazon to open first cashierless shop

GMT 15:49 2014 Saturday ,10 May

11,000 new Syrian refugees arrive in Lebanon

GMT 13:28 2017 Friday ,31 March

Bershka launches debut make-up collection

GMT 20:52 2011 Thursday ,28 April

Vietnam\'s industrial output grows 14%

GMT 15:22 2014 Thursday ,27 November

UAE offered Dh16bn humanitarian aid in 3 years

GMT 10:21 2017 Monday ,16 January

Moroccan E-learning Platform to Be Launched in 2019

GMT 06:43 2017 Saturday ,19 August

US judge rejects Polanski victim's bid to close case

GMT 18:09 2017 Thursday ,14 December

FA gives United, City more time to explain bust-up

GMT 19:37 2017 Wednesday ,08 November

Tokyo's main stock index closes at quarter-century high

GMT 14:13 2012 Friday ,15 June

Large asteroid to race by Earth

GMT 19:24 2017 Wednesday ,23 August

GPIC honours employee for academic achievement

GMT 22:59 2014 Monday ,29 December

Palestine condemns murder of minor in Nablus

GMT 22:50 2014 Friday ,17 October

Bahrain cultural advisor visits French institutes

GMT 12:11 2011 Monday ,17 October

Liberia prepares for presidential run off elections

GMT 22:05 2014 Thursday ,30 October

Funeral museum rises again in death-fixated Vienna

GMT 00:09 2015 Wednesday ,15 April

Ebola-hit Sierra Leone goes back to school

GMT 14:10 2014 Tuesday ,02 December

Kuwait Stock Exchange indexes in upward trend

GMT 22:22 2017 Saturday ,04 March

One militant killed in encounter in Tral

GMT 21:06 2014 Tuesday ,18 November

Rector of Zaytuna University meets Saudi ambassador
Almaghrib Today, almaghrib today
 
 Almaghrib Today Facebook,almaghrib today facebook  Almaghrib Today Twitter,almaghrib today twitter Almaghrib Today Rss,almaghrib today rss  Almaghrib Today Youtube,almaghrib today youtube  Almaghrib Today Youtube,almaghrib today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

.almaghribtoday .almaghribtoday .almaghribtoday .almaghribtoday
almaghribtoday almaghribtoday almaghribtoday
almaghribtoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
almaghribtoday, Almaghribtoday, Almaghribtoday